Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) was up 0.3% on Tuesday . The stock traded as high as $6.80 and last traded at $6.65. Approximately 7,908 shares were traded during mid-day trading, a decline of 2% from the average daily volume of 8,100 shares. The stock had previously closed at $6.63.
Fortress Biotech Stock Up 0.3 %
The business has a 50 day simple moving average of $6.70 and a 200-day simple moving average of $6.33.
About Fortress Biotech
Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.
Recommended Stories
- Five stocks we like better than Fortress Biotech
- Business Services Stocks Investing
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
